Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 11/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 8/20 | 0.37 |
| ▸ | ANO1 | Q5XXA6 | 4/20 | 0.36 |
| ▸ | F2 | P00734 | 8/20 | 0.36 |
| ▸ | PLAU | P00749 | 3/20 | 0.36 |
| ▸ | PLAT | P00750 | 3/20 | 0.36 |
| ▸ | F9 | P00740 | 1/20 | 0.35 |
| ▸ | F7 | P08709 | 1/20 | 0.34 |
| ▸ | PLG | P00747 | 2/20 | 0.34 |
| ▸ | KLK1 | P06870 | 1/20 | 0.34 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6941617 | 0.99 | F10 (0.37) | F10PRSS1ANO1F2PLAU | |
| Hydrochloric Acid SCHEMBL6939201 | 0.83 | F2 (0.41) | F10PRSS1F2F7 | |
| SCHEMBL7071377 | 0.78 | KLK5 (0.41) | F10PRSS1ANO1F2KLK1 | |
| Hydrochloric Acid SCHEMBL6943397 | 0.77 | KLK5 (0.41) | F10PRSS1ANO1F2KLK1 | |
| SCHEMBL7562464 | 0.76 | KLK5 (0.42) | F10PRSS1F2F7KLK1 | |
| SCHEMBL7562571 | 0.75 | KLK5 (0.39) | F10PRSS1ANO1F2F7 | |
| Hydrochloric Acid SCHEMBL7566109 | 0.75 | KLK5 (0.39) | F10PRSS1ANO1F2F7 | |
| SCHEMBL7569014 | 0.74 | MEN1 (0.48) | F10PRSS1F2F9KLK5 | |
| SCHEMBL7124379 | 0.74 | ANO1 (0.44) | F10PRSS1ANO1F2PLAU | |
| Hydrochloric Acid SCHEMBL6939888 | 0.74 | MEN1 (0.48) | F10PRSS1F2F9KLK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020183519-A1 | Antithrombotic carboxylic acid amides | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-12-05 | — | — | US | claimed |
| US-20020183519-A1 | Antithrombotic carboxylic acid amides | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-12-05 | — | — | US | disclosed |
| US-20020183519-A1 | Antithrombotic carboxylic acid amides | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183519-A1 | Antithrombotic carboxylic acid amides | SERPINC1, TFPI, F2 | F10 33/4885PRSS1 1106/4885ANO1 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.